|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.21/-0.44
|
企業價值
91.26M
|
資產負債 |
每股賬面淨值
1.05
|
現金流量 |
現金流量率
--
|
損益表 |
收益
19.61M
|
每股收益
0.89
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比較之報價最少15分鐘延遲
業務概覽
|
|||
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging andComputed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other. |